New pill aims to shrink spleens in bone marrow cancer patients
NCT ID NCT05020652
First seen Jan 04, 2026 · Last updated Apr 30, 2026 · Updated 22 times
Summary
This study tests a new tablet called TQ05105 against a standard drug, hydroxyurea, in people with moderate to high-risk myelofibrosis, a type of bone marrow cancer. The main goal is to see if TQ05105 can shrink the spleen by at least 35% after 24 weeks. About 107 adults aged 18-75 are taking part, and the study is currently active but not recruiting new participants.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MODERATE AND HIGH RISK MYELOFIBROSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Guangdong Provincial Peoples Hospital
Guangzhou, Guangdong, 510055, China
-
Institute of Hematology & Blood Diseases Hostpital, Chinese Academy of medical sciences & Peking Union Medical College
Tianjin, Tianjin Municipality, 300020, China
-
Peking Union Medical College Hospital
Beijing, Beijing Municipality, 100005, China
-
West China School of Medicine / West China Hospital, Sichuan University
Chengdu, Sichuan, 610041, China
Conditions
Explore the condition pages connected to this study.